GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Helyezés a részvények között
#3780
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Részvényárfolyam
$25.73
Piaci kapitalizáció
$4.36B
Változás (1 nap)
-5.33%
Változás (1 év)
-17.92%
Ország
IN
Kereskedés GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategória
Healthcare
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) P/B aránya
P/B arány ekkor: October 2026 TTM: 18.18
GlaxoSmithKline Pharmaceuticals Limited legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi könyv szerinti árfolyam aránya (P/B, TTM) 18.18. 2025 végén ez az arány 24.29 volt.
P/B arány története a(z) GlaxoSmithKline Pharmaceuticals Limited esetén 2004 és 2026 között
P/B arány az év végén
| Év | P/B arány | Változtassa meg |
|---|---|---|
| 2026 (TTM) | 18.18 | -25.14% |
| 2025 | 24.29 | 28.30% |
| 2024 | 18.93 | 46.14% |
| 2023 | 12.95 | 15.61% |
| 2022 | 11.20 | -32.14% |
| 2021 | 16.51 | 41.12% |
| 2020 | 11.70 | 13.72% |
| 2019 | 10.29 | 18.79% |
| 2018 | 8.66 | -25.23% |
| 2017 | 11.58 | -39.20% |
| 2016 | 19.05 | 60.47% |
| 2015 | 11.87 | -7.01% |
| 2013 | 12.77 | 39.51% |
| 2012 | 9.15 | 7.51% |
| 2011 | 8.51 | -16.10% |
| 2010 | 10.15 | 32.71% |
| 2009 | 7.64 | 23.58% |
| 2008 | 6.19 | -1.82% |
| 2007 | 6.30 | -22.76% |
| 2006 | 8.16 | -19.22% |
| 2005 | 10.10 | 38.74% |
| 2004 | 7.28 | 0.00% |
P/B arány hasonló vállalatoknál vagy versenytársaknál
| Vállalat | P/B arány | P/B arány különbség | Ország |
|---|---|---|---|
| 31.9092 | 75.49% |
US
|
|
| 7.8748 | -56.69% |
US
|
|
| -84.9599 | -567.25% |
US
|
|
| 8.6873 | -52.22% |
US
|
|
| 8.4776 | -53.38% |
CH
|
